Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
30 janv. 2020 07h00 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced sales of SofPulse® units to multiple Plastic Surgery...
Endonovo Therapeutics Provides SofPulse® To All NFL Teams
23 déc. 2019 08h30 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...
FDA Accepts SHINKEI Therapeutics Investigational New Drug Application for MR-301 for Traumatic Brain Injury
28 août 2019 08h00 HE
|
SHINKEI Therapeutics
PRINCETON, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- SHINKEI Therapeutics., a clinical stage pharmaceutical company focused on the development of therapeutic drugs for the treatment of Central Nervous...
Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury
21 août 2019 08h33 HE
|
Aptinyx Inc.
EVANSTON, Ill., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
Study Finds First Effective Scalable Intervention for Mild Traumatic Brain Injury
16 mai 2019 07h55 HE
|
Posit Science
WASHINGTON D.C., May 16, 2019 (GLOBE NEWSWIRE) -- A study run at five military and veterans’ hospitals has identified the first highly-scalable intervention for addressing cognitive deficits that...
CSI and BlackBox Biometrics Awarded $6.4 Million Contract for 10,000 Blast Gauge® Systems to Monitor Blast Exposed DoD Personnel
15 mai 2019 09h00 HE
|
Critical Solutions International
CHARLESTON, S.C., May 15, 2019 (GLOBE NEWSWIRE) -- Critical Solutions International (CSI) and partner BlackBox Biometrics (B3) announced today that the Henry M. Jackson Foundation for the...
Qrons Appoints Dr. Motti Ratmansky as Special Advisor for IND & Clinical Trial Preparations
08 mai 2019 09h00 HE
|
Qrons Inc.
New York, NY, May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions to...
Endonovo Therapeutics Hires Nevena Zubcevik of Harvard Medical School as Chief Medical Officer
02 mai 2019 09h20 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, May 02, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced the appointment of Nevena Zubcevik, DO, MSPT, ATC as its chief medical officer starting...
Endonovo Therapeutics Provides Corporate Update
26 avr. 2019 08h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, April 26, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Announces New Website Launch
27 févr. 2019 08h00 HE
|
Endonovo Therapeutics, Inc.
The completely redesigned website offers visitors deeper insight into the Company's core product, SofPulse® LOS ANGELES, CA, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:...